Icosavax Stock Price To Book
Icosavax fundamentals help investors to digest information that contributes to Icosavax's financial success or failures. It also enables traders to predict the movement of Icosavax Stock. The fundamental analysis module provides a way to measure Icosavax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icosavax stock.
Icosavax |
Icosavax Company Price To Book Analysis
Icosavax's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Icosavax Price To Book | 3.31 X |
Most of Icosavax's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icosavax is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Icosavax has a Price To Book of 3.3094 times. This is 87.11% lower than that of the Biotechnology sector and 45.21% lower than that of the Health Care industry. The price to book for all United States stocks is 65.2% higher than that of the company.
Icosavax Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icosavax's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics of similar companies.Icosavax is currently under evaluation in price to book category among its peers.
Icosavax Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.27 | |||
Current Valuation | 547.9 M | |||
Shares Outstanding | 50.23 M | |||
Shares Owned By Insiders | 3.47 % | |||
Shares Owned By Institutions | 87.64 % | |||
Number Of Shares Shorted | 321.31 K | |||
Price To Earning | 63.56 X | |||
Price To Book | 3.31 X | |||
Price To Sales | 153.31 X | |||
Gross Profit | (30.97 M) | |||
EBITDA | (103.19 M) | |||
Net Income | (96.71 M) | |||
Cash And Equivalents | 242.8 M | |||
Cash Per Share | 6.09 X | |||
Total Debt | 8.79 M | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 20.89 X | |||
Book Value Per Share | 4.64 X | |||
Cash Flow From Operations | (71.48 M) | |||
Short Ratio | 0.34 X | |||
Earnings Per Share | (2.20) X | |||
Target Price | 18.5 | |||
Number Of Employees | 60 | |||
Beta | 1.28 | |||
Market Capitalization | 769.04 M | |||
Total Asset | 238.68 M | |||
Retained Earnings | (185.83 M) | |||
Working Capital | 210.12 M | |||
Z Score | 51.0 | |||
Net Asset | 238.68 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Icosavax Stock
If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |